Quantum-Si Incorporated (NASDAQ: QSI) shares were in negative territory Tuesday. The firm dubbing itself “The Protein Sequencing Company” announced that it has entered into an agreement with a new international distributor as demand grows for its first-to-market next-generation protein sequencing™ instrument, Platinum™.
3Genes Distribution a.s., a prominent technology provider specializing in life science and diagnostics in Eastern Europe will distribute Quantum-Si’s Platinum across the Czech Republic, Slovakia, and Hungary. Dominik Véle, a board member of 3Genes said, “Through our agreement with Quantum-Si, 3Genes aims to pioneer proteomic innovation in our Eastern European markets, forging a new era in life sciences.”
"Expanding our reach through agreements with an industry leader like 3Genes aligns with our mission to revolutionize proteomics," remarked CEO Jeff Hawkins. "We are thrilled to welcome this esteemed distributor to our global network, enabling scientists worldwide to harness the power of Platinum and drive groundbreaking discoveries."
This strategic agreement marks another milestone in Quantum-Si's efforts to unleash the power of proteomics in every lab, everywhere. It follows closely on the heels of the company’s recently announced agreement with ELTA 90, a Bulgarian distributor to distribute Platinum in Southeast Europe.
For its part, 3Genes is a technology provider for life-science and diagnostics. The company provides technological solutions in the field of next-generation sequencing, proteomics and spatial transcriptomics.
QSI shares lost 2.5 cents, or 1.7%, to $1.48.
